VANCOUVER, British Columbia, May 14, 2019 /PRNewswire/ — ParcelPal Technology Inc. (“ParcelPal” or the “Company”), (PKG.CN) (PKG.CN) (PT0.F) (PTNYF) is pleased to welcome Ontario MP Parm Gill as an advisor to the Board of Directors.
Parm Gill is the current Member of Provincial Parliament for Milton. Prior to his work in public service, Parm was involved in several family businesses in the manufacturing and hospitality industries. Parm studied at the Ivey School of Business at Western University, earning his Master of Business Administration degree.
Before being elected to the Ontario Legislature in 2018, Parm was the Federal Member of Parliament for Brampton-Springdale from 2011-2015.
While serving as the MP in the Canadian House of Commons, Parm was appointed as the Parliamentary Secretary to the Minister of Veteran Affairs, and later, the Minister of International Trade. Throughout his tenure, Parm was a member of many committees including the Standing Committee of Public Safety and National Security, Health, Canadian Heritage, Veterans Affairs, and International Trade.
REPORT: Special Delivery! On-Demand Tech Companies Hit Billion-Dollar Valuations; Here’s How Investors Can Capitalize In The Market
In 2012, Parm introduced a Private Member’s Bill, C-394. His bill introduced a new Criminal Code offense: prohibiting the recruitment or encouragement of a person to join a criminal organization. The bill passed with unanimous consent and became law in June 2014. The bill works to keep our streets, neighbourhoods, and committees safer which has always been a top priority for Parm.
As Chair of the Standing Committee on Justice Policy, Parm continues his advocacy work to keep our communities safe. The committee is responsible for studying and providing recommendations on bills related to policing and the courts.
President and CEO Kelly Abbott states, “I am very excited to have Parm join the Advisory Board. Mr. Gill’s knowledge on economic issues and private sector experience will be an asset for ParcelPal moving forward. Mr. Gill has changed criminal law for the better and is always looking for the betterment of safety for all Canadians.”
Parm Gill stated, “I am excited to be joining a company that has put public safety first. As ParcelPal moves further into cannabis and alcohol delivery, I am happy to advise on how they can continue the fight against intoxicated people on the roads and getting their products safely. ParcelPal has a bright future and I am excited to be part of a team that will grow their business across Canada and the United States.”
About ParcelPal Technology Inc.
ParcelPal is a technology-driven logistics company that connects consumers to the goods they love. Customers can shop at partner businesses and through the ParcelPal technology receive their purchased goods within an hour. The Company offers on-demand delivery of merchandise from leading retailers, restaurants, medical marijuana dispensaries and liquor stores in Vancouver and soon in major cities Canada-wide.
ParcelPal Website: www. parcelpal . com
The Canadian Securities Exchange (“CSE”) or any other securities regulatory authority has not reviewed and does not accept responsibility for the adequacy or accuracy of this news release that has been prepared by management.
CSE – Symbol: PKG
FSE – Symbol: PT0
OTC – Symbol: PTNYF
Forward Looking Information
This news release contains forward looking statements relating to the Proposed Transaction, and the future potential of ParcelPal. Forward looking statements are often identified by terms such as “will”, “may”, “should”, “intends”, “anticipates”, “expects”, “plans” and similar expressions. All statements other than statements of historical fact, included in this release are forward looking statements that involve risks and uncertainties. These risks and uncertainties include, without limitation, the risk that the Proposed Transaction will not be completed due to, among other things, failure to execute definitive documentation, failure to complete satisfactory due diligence, failure to receive the approval of the CSE and the risk that ParcelPal will not be successful due to, among other things, general risks relating to the mobile application industry, failure of ParcelPal to gain market acceptance and potential challenges to the intellectual property utilized in ParcelPal. There can be no assurance that any forward looking statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.
The Company cannot guarantee that any forward looking statement will materialize and the reader is cautioned not to place undue reliance on any forward looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward looking statements contained in this news release are expressly qualified by this cautionary statement. The forward looking statements contained in this news release are made as of the date of this news release and the Company will only update or revise publicly any of the included forward looking statements as expressly required by Canadian securities laws.
peter@ parcelpal . com
ParcelPal to distribute Yield’s cosmetics in Vancouver
ParcelPal Technology Inc. (PTNYF) (PKG.CN) has formed an alliance with Canadian cannabis topicals company, The Yield Growth Corp., for same-day and on-demand delivery, sale, of hemp-based cosmetics from Yield Growth’s subsidiary Urban Juve in Canada.
This initiative between Yield Growth and ParcelPal will commence in Vancouver as the catalyst city, and it is expected that additional cities will be rapidly added to this distribution network across Canada. Urban Juve’s customers will be able to purchase through Urban Juve’s website ( www.urbanjuve.com ) and ParcelPal will create an exclusive marketplace applications. Urban Juve hemp products are currently sold in over 90 locations including well known pharmacy chains across North America, with a plan to expand that to 130 retail outlets in the near future.
Customers will be able to track their purchase in real time and have their product delivered to any location they specify. As time and regulations allow, ParcelPal’s cannabis network will continue to grow, with the goal of capturing a major piece of Canada’s $5.2 B legal cannabis market.
President and CEO, Kelly Abbott states, “ParcelPal is thrilled to be working an innovative company such as The Yield Growth’s Corp, which is addressing one of the fastest-growing subsegments of the $4.2 trillion wellness market with unique derived and cannabis infused products. This marks a milestone at ParcelPal, launching a new vertical with substantial growth potential. It’s also a unique opportunity to be at the forefront of an exciting new industry with our unique logistics solutions.”
President and CEO of The Yield Growth Corp. Penny Green States “This new agreement is part of our continued efforts to serve our customers as seamlessly as possible,” says Penny Green, CEO of Yield Growth Corp. “ParcelPal is a great service, and our alliance will lay the groundwork for us to eventually offer same-day delivery service for pain management cannabis topicals and other cannabis products in jurisdictions where they’re legal.”
About The Yield Growth Corp.
The Yield Growth Corp. develops, manufactures and distributes cannabis and hemp infused luxury product brands Urban Juve and Wright & Well, and has a catalogue of over 200 wellness and beauty formulas. It intends to disrupt the international wellness market which is a 4.2 trillion global economy, according to the Global Wellness institute, by connecting ancient healing with modern science and technology. It’s management team has deep experience with global brands including Johnson & Johnson, Proctor and Gamble, M-A-C cosmetics, Sketchers, Best Buy Aritzia, Coca-Cola, and Pepsi Corporation. Yield Growth Serves mainstream luxury customers who seek sophisticated wellness products. It has flagship consumer brand, Urban Juve, has proprietary, patient pending hemp root extraction technology and has 12 patents pending. Yield Growth is building sophisticated international distribution channels and has multiple revenue streams including licensing, services and products.
About ParcelPal Technology Inc.
ParcelPal is a technology-driven logistics company that connects consumers to the goods they love. Customers can shop at partner businesses and through the ParcelPal technology receive their purchased goods within an hour.
The Company offers on-demand delivery of merchandise from leading retailers, restaurants, medical marijuana dispensaries and liquor stores in Vancouver and soon in major cities Canada-wide. ParcelPal Website: www.parcelpal.com
3 Cannabis Stocks In Focus This Week
One of the sectors that have enjoyed exponential growth over the past year or so is the marijuana sector and during the period, many of the stocks have gained significantly on the back of heightened investor interest.
It’s necessary to point out that in a fast-growing industry, it’s possible for stocks to rise significantly as well as the industry going through a fair bit of churn. Hence, investors could make significant returns if they manage to choose the right stock. Here is a look at 3 cannabis stocks.
Cannabis Stock To Watch #1: Driven Deliveries
Driven Deliveries (DRVD) focuses on several segments of the cannabis industry. Its leading service is for marijuana delivery in the United States. And this summer has been a busy time for Driven Deliveries. Most recently the company signed 10 brands as part of Driven’s Brand to Consumer cannabis delivery service.
In each of the partnerships, Driven has secured the rights to provide each brand with its own unique and branded e-commerce store with the transaction completed and fulfilled by Driven. Through the 10 branded e-commerce stores, and the Ganjarunner online store, Driven and its brand partners offer more than 500 retail items.
This includes edibles, topicals, elixirs, concentrates, smokable products, storage, apparel and accessories to customers in California. Because California is expected to reach over $4.7 billion in cannabis sales by 2025, the timing of this expansion could be opportune for the company.
Over the last few months, shares of Driven have traded in a range of $0.60 to $1.00 and are currently near the lower end of that range. Since the cannabis industry has started to see a resurgence of activity due to things like new ETF’s going live, the next move for the sector could be exciting to watch.
Cannabis Stock To Watch #2: CannTrust Holdings
CannTrust Holdings (TSX:TRST) (NYSE:CTST) is among the bigger producers of cannabis in the industry but the company had a setback on Monday after it emerged that one of its plants in Pelham had produced cannabis without a license from Health Canada. It happened in the months prior to the company getting its license in March.
5200 kilos of the production from the period is now going to be tested for compliance while 7500 kilos from another plant has been voluntarily held back by CannTrust. The shares fell by 22% on Monday but it should be noted that the company’s facilities are currently fully compliant with Health Canada regulations.
Cannabis Stock To Watch #3: OrganiGram Holdings
The other marijuana penny stock that gained last week due to an unexpected endorsement from one of the titans of the industry was OrganiGram Holdings (TSXV:OGI) (NASDAQ:OGI). The stock surged by as much as 8% after the former CEO and founder of industry leader Canopy Growth Brian Linton picked it as the one company with the potential for the biggest growth in the future.
Linton was voted out by the board of Canopy Growth but when asked about the company he likes, he stated that he had a good experience while dealing with OrganiGram in the past.
Premier Health and CB2 Insights Move to Second Phase of Primary Care Physician Tools for Medical Cannabis Evaluation
VANCOUVER, British Columbia, July 09, 2019 (GLOBE NEWSWIRE) — Premier Health Group (CSE: PHGI, OTCQB: PHGRF, Frankfurt: 6PH) (the “Company” or “Premier Health”), a Company focused on developing innovative approaches that combine human skill-based expertise with emerging technologies for the healthcare industry, has successfully completed Phase One of CB2 Insights’ (CSE:CBII) Clinical Decision Support (CDS) tool integration including targeted user testing.
Premier Health’s leading Electronic Medical Records (EMR) platform, Juno, will provide access to its over 4,600 primary care physician and healthcare practitioner users to the industry’s only data-driven platform that guides clinicians through the evaluation process for medical cannabis treatment. After a successful completion and user feedback within this first stage, both parties anticipate full rollout will be completed in Q3.
The agreement will be the first of its kind, with primary care physicians previously lacking the resources and tools required to assess the validity of medical cannabis as a treatment option for their patients. The CDS tool provides comprehensive guidelines for physicians to input patient-specific parameters into the system which is powered by proprietary algorithms leveraging data from more than 500 clinical research papers and trials as well as the anonymized and aggregate data of more than 450,000 patient encounters that CB2 Insights has managed through its clinical arm.
“At Premier Health, our mission is to integrate the best CDS tools directly into our Juno EMR platform that will equip physicians to make enhanced health-related decisions,” said Dr. Essam Hamza, CEO of Premier Health. “Our work with CB2 Insights has been long awaited by physicians who understand the benefits of medical cannabis, however are unsure of how to incorporate it within their clinics. We are excited to be bringing this robust and medically validated tool to our Juno userbase.”
“Physicians are the gatekeepers to any pharmacological treatment option for patients and enabling them to include medical cannabis into those options is a key advancement in the industry that all stakeholders should be excited about,” said Prad Sekar, CEO of CB2 Insights. “The success of this project thus far is confirmation that healthcare practitioners have been awaiting the tools that will help them remove the barriers that persist in the complicated world of medical cannabis. When you are dealing with a new treatment that can be applied to a wealth of patient indications from chronic pain to anxiety to sleep disorders and so on, paired with an array of medicine with varying levels of strength and outcome, we are proud to have created a tool that has received overwhelming physician support in this first stage.”
As part of Phase One, users were given the opportunity to test the system and provide feedback on both the applicability and user experience of the tool. The group of physicians who took part in Phase One included cannabis naïve physicians as well as those with advanced medical cannabis experience. Based on the positive feedback received from physicians, both parties agreed to immediately move into the final integration phase.
This agreement marks the first full-scale commercialization of CB2 Insights’ Data Insights business unit. CB2 Insights expects to monetize this tool through subscription of data reports paid for by Cannabis Licensed Producers from the aggregate and anonymized data collected on Canadian products. These reports will provide Producers with much needed clinically-generated efficacy data on specific products as well as the aggregate data to support research & development efforts and future commercialization. CB2 has already had successful conversations with Licensed Producers who have shown early commitment to subscribe to these reports.
As part of the agreement, CB2 will provide the development and continuous maintenance and support of the CDS tool and all related technologies. Premier Health will support the partnership by providing access to their software and will engage in education and training to its growing network of physicians and other healthcare professionals.
ON BEHALF OF THE BOARD OF DIRECTORS
“Dr. Essam Hamza, MD”
Chief Executive Officer
About Premier Health
Premier Health is a Canadian company that is strategically poised to take advantage of business opportunities in the global health care industry. We are focused on innovative health care approaches that combine human skill-based expertise with emerging technologies. Premier Health, in conjunction with its subsidiary Cloud Practice, a cloud-based SAAS Electronic Medical Records software company, is developing proprietary technology to deliver quality healthcare through the combination of connected primary care clinics with telemedicine and artificial intelligence (AI). We currently have a combined ecosystem of 290 clinics, over 3000 licensed practitioners and almost 3 million registered patients. The Premier Health team has deep clinical, operational and financial expertise and a passion for improving healthcare for all patients.
For more information on Juno EMR, please visit www.j unoemr. com.
About CB2 Insights
CB2 Insights has a mission to mainstream medical cannabis into traditional healthcare. We do so by gathering data and creating objective real-world evidence through our proprietary software and service brands. Using clinical management and data collection software at the point-of-care, CB2 Insights and its group of sub-brands has become a leading force behind bringing traditional healthcare protocols to the rapidly evolving global cannabis industry.
For more information please visit www.cb2insights.com.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
FOR ADDITIONAL INFORMATION CONTACT:
Premier Health Group Inc.
Email: investors@ mypremierhealth .com
Renmark Financial Communications Inc.
Bettina Filippone: bfilippone @renmarkfinancial .com
Tel:(416) 644-2020 or (514) 939-3989
www. renmarkfinancial .com
Search Stock Price (StockPrice.com)
Sponsored Content1 month ago
Special Delivery! On-Demand Tech Companies Hit Billion-Dollar Valuations; Here’s How Investors Can Capitalize In The Market
Featured4 months ago
Multi-Trillion Dollar Industry Providing Massive Opportunity in 2019 & Beyond
Cannabis3 months ago
Two Massive Growth Industries, One Choice for Investors
Biotechnology1 month ago
Big Investments Are Signaling The Green Light For A ‘Hot Market’ With Cancer-Fighting Stocks
Featured1 month ago
This New Technology Could Transform A Multi-Billion-Dollar Industry!
Cannabis2 months ago
A New Cannabis Trend That The Market Should Take Immediate Notice Of Is Here!
Biotechnology2 weeks ago
The Future Of Drug Delivery Has Biotech Investors Focusing On One Small Company
Featured3 months ago
Opportunity Ahead for This Healthcare Stock